CERS

Cerus Corporation Healthcare - Medical Devices Investor Relations →

YES
1.0% BELOW
↓ Approaching Was 0.5% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $2.00
14-Week RSI 42
Rel. Volume (14w) This week's trading vs. the 14-week average 1.6x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.01

Cerus Corporation (CERS) closed at $1.99 as of 2026-11-13, trading 1.0% below its 200-week moving average of $2.00. This places CERS in the below line zone. The stock is currently moving closer to the line, down from 0.5% last week. The 14-week RSI sits at 42, indicating neutral momentum.

Trading volume is running at 1.6x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.01 ratio) is neutral — neither side is clearly dominating.

Over the past 1506 weeks of data, CERS has crossed below its 200-week moving average 28 times. On average, these episodes lasted 28 weeks. Historically, investors who bought CERS at the start of these episodes saw an average one-year return of +12.9%.

With a market cap of $401 million, CERS is a small-cap stock. The company generates a free cash flow yield of 0.5%. Return on equity stands at -10.7%. The stock trades at 5.3x book value.

Share count has increased 8.2% over three years, indicating dilution.

Over the past 28.9 years, a hypothetical investment of $100 in CERS would have grown to $12, compared to $1257 for the S&P 500. CERS has returned -7.2% annualized vs 9.1% for the index, underperforming the broader market over this period.

Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: CERS vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After CERS Crosses Below the Line?

Across 27 historical episodes, buying CERS when it crossed below its 200-week moving average produced an average return of +12.6% after 12 months (median +9.0%), compared to +10.1% for the S&P 500 over the same periods. 60% of those episodes were profitable after one year. After 24 months, the average return was +50.0% vs +22.7% for the index.

Each line shows $100 invested at the moment CERS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices CERS would reach each dislocation threshold.

Current Bean Score +1.22σ
Current FCF Yield 0.12%
Baseline Yield 0.11%
Historical σ 0.04pp

Dislocation Price Levels

Prices where CERS's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-09-30).

LevelσPriceSignal
Deep Value+2σ$1.56Unusually cheap — analysis point
Value+1σ$2.16Cheap vs. own history
Fair Value+0σ$3.50Historical mean behavior
Expensive-1σ$9.30Expensive vs. own history
Deep Expensive-2σN/AUnusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-07-30$-0.01$-0.01—
2026-04-30$-0.04$-0.01+71.4%
2026-03-02—$-0.01-100.0%
Data depth: 2 quarterly baselines, 19 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

21 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from CERS's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation N/A Dividend yield vs own 10-yr norm
Drawdown Score -0.07σ Distance from line vs own history
Sector-Relative -0.06σ Vs sector median this week
Buyback Acceleration +0.7pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History +4.7pp Vs own recent annual mean
Earnings Quality Improving Accrual gap trend (-3.2pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

CERS has crossed below its 200-week MA 28 times with an average 1-year return of +12.9% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Apr 1998Jul 19981319.3%+15.8%-86.8%
Aug 1998Oct 1998822.0%+82.8%-86.7%
Nov 1998Nov 199811.3%+95.6%-87.2%
Nov 1998Dec 199813.8%+90.9%-86.9%
Apr 1999May 199924.7%+128.6%-87.7%
Jun 2002Jan 200618893.5%-74.0%-94.5%
Apr 2006May 2006712.4%-7.5%-74.9%
Jul 2006Oct 20061218.4%+3.4%-69.6%
Jan 2007Feb 200766.6%+17.4%-63.2%
Feb 2008Mar 2008726.3%-86.8%-66.9%
Apr 2008Oct 201118490.1%-82.1%-67.4%
Nov 2011Nov 201110.4%+13.7%-28.3%
Jul 2014Sep 201486.2%+46.4%-48.8%
Sep 2014Oct 201437.3%+33.6%-47.9%
Mar 2015Apr 201566.7%+37.1%-51.8%
Oct 2016Nov 201647.5%-39.8%-61.6%
Nov 2016Mar 20186657.6%-21.9%-60.1%
Dec 2018Dec 201820.8%-16.6%-60.2%
May 2019Jun 2019411.6%+32.6%-57.7%
Sep 2019Sep 201912.5%+15.0%-60.7%
Sep 2019Feb 20202121.7%+25.1%-59.2%
Mar 2020Apr 2020436.7%+55.5%-51.7%
May 2021Jun 202113.0%-6.4%-62.9%
Jul 2021Aug 2021412.8%+9.9%-62.3%
Jan 2022Jan 202620974.4%-46.2%-66.0%
Jan 2026Feb 202638.6%N/A-14.8%
Mar 2026Apr 2026827.7%N/A+2.8%
Nov 2026Ongoing1+1.0%OngoingN/A
Average28—+12.9%—

Frequently Asked Questions

Is CERS below its 200-week moving average?

Yes. As of 2026-11-13, Cerus Corporation (CERS) is trading 1.0% below its 200-week moving average of $2.00. The current price is $1.99.

What is CERS's 200-week moving average price?

Cerus Corporation's 200-week moving average is $2.00 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when CERS drops below its 200-week moving average?

CERS has crossed below its 200-week moving average 28 times in our data. On average, buying at that moment produced a one-year return of +12.9%. These dips have historically been decent entry points. These episodes lasted 28 weeks on average.

Is CERS a good value right now?

Here's what our data says about CERS as of 2026-11-13: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 42. Free cash flow yield is 0.5%. Return on equity is -10.7%. Price-to-book is 5.3x. This is not a buy or sell recommendation — always do your own research.

How does CERS compare to the S&P 500?

Over the past 28.9 years, $100 invested in CERS would have grown to $12, compared to $1257 for the S&P 500. That's -7.2% annualized vs 9.1% for the index. CERS has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13